Application 208079
- Type
- NDA
- Sponsor
- ENCORE DERMAT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SERNIVO | BETAMETHASONE DIPROPIONATE | SPRAY;TOPICAL | EQ 0.05% BASE/SPRAY | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 67857-808 | Sernivo | betamethasone dipropionate | Promius Pharma, LLC | NDA | Current |
| 68040-714 | Sernivo | betamethasone dipropionate | Primus Pharmaceuticals, Inc. | NDA | Current |
| 68040-714 | Sernivo | betamethasone dipropionate | Primus Pharmaceuticals, Inc. | NDA | Current |
| 68040-714 | Sernivo | betamethasone dipropionate | Primus Pharmaceuticals, Inc. | NDA | Current |
| 69482-800 | Sernivo | betamethasone dipropionate | Encore Dermatology Inc. | NDA | Current |